Creating web questionnaire system related to thalidomide education and managment system (terms)

  • At: 2017 FIP Congress in Seoul (South Korea)
  • Type: Poster
  • By: HORI, Kanako (Osaka University, School of Pharmaceutical Sciences, Suita, Japan)
  • Co-author(s): Kanako Hori
    Yuko Shirakuni
    Hirotomo Moriwaki
    Yu-Shi Tian
    Norihito Kawashita
    Tatsuya Takagi
  • Abstract:

    Background

    In Japan, thalidomide has been approved for use in multiple myeloma since 2008 and has been available since 2009 under the Risk Management Program (RMP) named Thalidomide Education and Risk Management System (TERMS). In order to analyze the current compliance status of TERMS in medical institutions, mail-back questionnaire surveys for..

  • The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress. Please login